Takeda and Carmine Enter $900 Million Non-Viral Gene Therapy Collaboration

Submitted by admin on July 1, 2020 - 10:51am

Source:

BioSpace

News Tags:

Carmine Therapeutics

Takeda

gene therapy

Headline:

Takeda and Carmine Enter $900 Million Non-Viral Gene Therapy Collaboration

snippet:

Cambridge, Massachusetts-based Carmine Therapeutics inked a research collaboration deal with Japan’s Takeda Pharmaceutical to develop and commercialize non-viral gene therapies for two rare diseases.

Search form

You are here

Takeda and Carmine Enter $900 Million Non-Viral Gene Therapy Collaboration

Takeda and Carmine Enter $900 Million Non-Viral Gene Therapy Collaboration